Abstract
Objective. Estimation of individual risk transformation of paroxysmal atrial fibrillation (AF) in the permanent form in medication treated ischemic heart disease (IHD) patients. Design and Methods. Analysis includes 149 IHD patients with paroxysmal AF. Their treatment consisted of drug combination usually used in IHD patients including beta-blockers. No other medications with antiarrhythmic properties were used. Comparisons between the means of the values were made by Student’s test and exact Fisher method. Selection of the factors most informative for risk of the paroxysmal AF transformation in the permanent form was realized with the logistic discriminant analysis. Results. Within three-years follow-up paroxysmal AF remained in 102 (68%) patients while in 47 (32%) cases it transformed in the permanent form of AF. It is revealed that risk of the paroxysmal AF transformation is associated with increase of aging, dimension of the left atrium, atrial ectopic activity and decrease of the left ventricle ejection fraction. Conclusion. The offered estimation of the individual paroxysmal AF transformation risk for IHD patients in the permanent form of AF during three-years follow-up period is characterized by high prognostic accuracy: 97% for preservation of paroxysmal AF, and 93% for its transformation in the permanent form.
Highlights
У остальных 102 (68%) сохранилась пароксизмальная форма фибрилляция предсердий (ФП)
1. У больных ишемической болезнью сердца (ИБС) риск трансформации пароксизмальной фибрилляция предсердий (ФП) в постоянную форму возрастает с увеличением возраста, размера левого предсердия, предсердной эктопической активности и при снижении фракции выброса левого желудочка
Summary
Ния исследования возможности индивидуального прогнозирования риска ее трансформации в постоянную форму ФП [5]. Цель настоящего исследования — оценка индивидуального риска трансформации пароксизмальной ФП в постоянную форму у больных ИБС, получающих медикаментозное лечение.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
